Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.

Article Details

Citation

Quane KA, Healy JM, Keating KE, Manning BM, Couch FJ, Palmucci LM, Doriguzzi C, Fagerlund TH, Berg K, Ording H, et al.

Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.

Nat Genet. 1993 Sep;5(1):51-5.

PubMed ID
8220423 [ View in PubMed
]
Abstract

Central core disease (CCD) of muscle is an inherited myopathy which is closely associated with malignant hyperthermia (MH) in humans. CCD has recently been shown to be tightly linked to the ryanodine receptor gene (RYR1) and mutations in this gene are known to be present in MH. Mutation screening of RYR1 has led to the identification of two previously undescribed mutations in different CCD pedigrees. One of these mutations was also detected in an unrelated MH pedigree whose members are asymptomatic of CCD. The data suggest a model to explain how a single mutation may result in two apparently distinct clinical phenotypes.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Ryanodine receptor 1P21817Details